MED TRANS
0735.391.939 · rovalta.com · 09/11/2026
MED TRANS
Financial year 2025 · Closed on 31/12/2025
Overview
Identity
Source · BCE/KBOMED TRANS is a Private limited company incorporated in 2019. Its main activity is: Freight transport by road. Its registered office is in Antwerpen.
- Legal situation
- Normal situation
- BCE/KBO no. / VAT
- BE 0735.391.939
- Incorporation
- 30/09/2019
- Legal form
- Private limited company
- Registered office
- Patronaatstraat 2
2180 Antwerpen · FlandreSee on map - Contributed capital
- 12 400,00 €
- Latest accounts
- 31/12/2025
Financials
Source · NBB, 6 filingsTrend over 6 financial years
| 2025 | 2024 | 2023 | 2022 | 2021 | |||||
|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||
| Gross margin | 147,1 k € | -3.3% | 152,1 k € | +60.8% | 94,6 k € | +126% | 41,8 k € | +8.6% | 38,5 k € |
| EBITDA | -22 k € | -176% | 28,9 k € | +149% | 11,6 k € | +40.7% | 8,3 k € | -71.3% | 28,7 k € |
| Operating result | -22 k € | -177% | 28,6 k € | +146% | 11,6 k € | +67.8% | 6,9 k € | -74.1% | 26,7 k € |
| Net result | -24,8 k € | -216% | 21,3 k € | +150% | 8,5 k € | +55.3% | 5,5 k € | -76.0% | 22,8 k € |
| Balance sheet | |||||||||
| Equity | 32,7 k € | -43.1% | 57,5 k € | +58.9% | 36,2 k € | +30.8% | 27,6 k € | +24.8% | 22,2 k € |
| Total assets | 178,9 k € | +70.3% | 105,1 k € | +46.2% | 71,9 k € | +6.1% | 67,8 k € | +38.9% | 48,8 k € |
| Cash | 30 k € | +66.3% | 18 k € | +594% | 2,6 k € | -1.7% | 2,6 k € | -24.5% | 3,5 k € |
| Debts | 146,2 k € | +207% | 47,6 k € | +33.2% | 35,7 k € | -11.0% | 40,1 k € | +50.7% | 26,6 k € |
Valuation
Indicative valuation
As an indication, this company is worth
Board of directors
Source · NBB, accounts to 31/12/20251 active · 1 ended
Active mandates
| Director | Mandates in this company | Period |
|---|---|---|
Mennah Mennah Abderrahim | Mandate |
Ended mandates
| Director | Mandates in this company | Period |
|---|---|---|
Ahmed Shafeeq | Mandate2021 accounts |
Financials
Full financial information
Source · NBB| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Type of account | Micro model | Micro model | Micro model | Micro model | Micro model | Micro model |
| Start of the financial year | 01/01/2025 | 01/01/2024 | 01/01/2023 | 01/01/2022 | 01/01/2021 | 26/06/2019 |
| Closing of the financial year | 31/12/2025 | 31/12/2024 | 31/12/2023 | 31/12/2022 | 31/12/2021 | 31/12/2020 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 12 months | 19 months |
| Filing date | 21/09/2026 | 12/09/2025 | 18/09/2024 | 28/01/2024 | 14/07/2022 | 30/12/2021 |
| General meeting | 01/06/2026 | 02/06/2025 | 03/06/2024 | 01/06/2023 | 01/06/2022 | 01/06/2021 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Source · NBBLooking for more information about this company?
Try for freeAnnual accounts filings
Source · NBB, 6 filings| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Micro model | 31/12/2025 | 01/06/2026 | 21/09/2026 | Dutch | |
| Micro model | 31/12/2024 | 02/06/2025 | 12/09/2025 | Dutch | |
| Micro model | 31/12/2023 | 03/06/2024 | 18/09/2024 | Dutch | |
| Micro model | 31/12/2022 | 01/06/2023 | 28/01/2024 | Dutch | |
| Micro model | 31/12/2021 | 01/06/2022 | 14/07/2022 | Dutch | |
| Micro model | 31/12/2020 | 01/06/2021 | 30/12/2021 | Dutch |
Valuation
Indicative valuation
As an indication, this company is worth
between 0 € and 100 k€
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Source · NBB, accounts to 31/12/20251 active · 1 ended
Active mandates
| Director | Mandates in this company | Period |
|---|---|---|
Mennah Mennah Abderrahim | Mandate |
Ended mandates
| Director | Mandates in this company | Period |
|---|---|---|
Ahmed Shafeeq | Mandate2021 accounts |
Ownership and network
Looking for more information about this company?
Try for freePublications
Belgian Official Gazette publications
Source · Belgian Official GazetteSimilar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
Source · CBE, NBB annual accountsRegistered offices
Source · NBB annual accounts, CBE| Registered address | Period | Source |
|---|---|---|
| Patronaatstraat 2, 2180 Ekeren (Antwerp)Current | accounts 2021 → 2025 | Accounts 2025 · 2026-00524152 |
Company names
Source · NBB annual accounts, CBE| Name | Period | Source |
|---|---|---|
| MED TRANSCurrent | accounts 2021 → 2025 | Accounts 2025 · 2026-00524152 |
Events
- 2025Annual accounts 2025-24,8 k €↓
- 2024Annual accounts 202421,3 k €↑
- 2023Annual accounts 20238,5 k €↑
- 2022Annual accounts 20225,5 k €↓
- 2021Annual accounts 202122,8 k €↑
- 2020Annual accounts 2020-13,1 k €
- 30/09/2019IncorporationPrivate limited company